---
title: "CUE-101with Pembrolizumab for LA-HPV+HNSCCs"
date: "2025-09-15T04:00:00.000Z"
publishedDate: "15 septembre 2025"
summary: "Conditions : Head and Neck Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; New Diagnosis Tumor; Locally Advanced Interventions : Drug: CUE-101; Drug: Pembrolizumab Sponsors : Yale University; Cue Biopharma; National Cancer Institute (NCI) Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07172256?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-15-cue-101with-pembrolizumab-for-la-hpvhnsccs"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Head and Neck Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; New Diagnosis Tumor; Locally Advanced Interventions : Drug: CUE-101; Drug: Pembrolizumab Sponsors : Yale University; Cue Biopharma; National Cancer Institute (NCI) Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07172256?term=interventional+radiology&aggFilters=status%3A
